55 results
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
against the minority shareholders or, for instance, where an act requires the approval of a greater percentage of the company’s shareholders than that which … to the relevant time.
Compulsory Acquisition of Shares Held by Minority Holders
An acquiring party is generally able to acquire compulsorily the common
424B5
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Prospectus supplement for primary offering
4:40pm
years prior to the relevant time.
Compulsory Acquisition of Shares Held by Minority Holders
An acquiring party is generally able to acquire … compulsorily the common shares of minority holders in the following ways:
(1) By a procedure under the Companies Act known as a “scheme of arrangement
424B5
oqhs2ny
8 Dec 21
Prospectus supplement for primary offering
4:37pm
F-3
zws5fq tdu2to0ff
16 Nov 21
Shelf registration (foreign)
5:05pm
424B5
trydru2 u3
15 Jan 21
Prospectus supplement for primary offering
4:32pm
424B5
ooxjak 8zrg73b
3 Dec 20
Prospectus supplement for primary offering
5:25pm
424B4
p41nunj7a7 l8ss
14 May 19
Prospectus supplement with pricing info
4:06pm
F-1/A
07kwhrv8gidw
10 May 19
Registration statement (foreign) (amended)
3:18pm
F-1/A
cfl3 aqep
6 May 19
Registration statement (foreign) (amended)
5:26pm
F-1
et17wb8xc2t3
30 Apr 19
Registration statement (foreign)
8:32am